ClinicalTrials.Veeva

Menu

TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish Population

R

Region Skane

Status

Completed

Conditions

Tremor
Dementia
Parkinsonism

Study type

Observational

Funder types

Other

Identifiers

NCT06032585
Dnr 2022-06697-01

Details and patient eligibility

About

Popular science summary of the project The purpose of the study is to investigate in a Swedish population how well the investigators' previous ultrasound findings match the final diagnosis (PD, APS or ET) after a particularly long follow-up time, which greatly increases the certainty that the diagnosis does not change more and is thus correct. Furthermore, the investigators want to study whether the initial ultrasound findings have changed during the control interval and whether measurement results regarding the diameter in one of the fluid-filled rooms in the brain (third ventricle) can be correlated with the development of cognitive impairment or dementia later in the course of the disease. For this, this study have got ethical permission to go into the patients' medical records and to call a subgroup back to the clinic to be able to do a new examination and a memory test.

Enrollment

74 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with parkinsonism or essential tremor who came into contact with our clinic before 2017
  • Satisfactory transcranial bone window
  • Previous TU (clinical indication)

Exclusion criteria

  • No transcranial bone window

Trial design

74 participants in 1 patient group

Patients with parkinsonism
Description:
Parkinsonism incl. tremor, parkinsons, atypical parkinsons

Trial contacts and locations

1

Loading...

Central trial contact

Markus Stiehm

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems